New Oral AntiCoagulants Use in REnal Disease and AF (NOACURE-AF) Where do we stand?: An expert consensus view using the Delphi method
Guardado en:
Autores principales: | Mustafa Arıcı, Tevfik Ecder, İzzet Erdinler, Ercan Ok, Özlem Arıcan Özlük, Uğur Önsel Türk, Emin Alioğlu |
---|---|
Formato: | article |
Lenguaje: | EN TR |
Publicado: |
KARE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/46c1a112cc2c4ea58cce28d139f4b156 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand? An expert consensus view using the Delphi method
por: Ali Çoner
Publicado: (2021) -
AF in Cancer Patients: A Different Need for Anticoagulation?
por: Ana Pardo Sanz, et al.
Publicado: (2019) -
Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
por: K Pukite, et al.
Publicado: (2020) -
Mainstreaming af kønsforskning
por: Inge Henningsen, et al.
Publicado: (2000) -
The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations
por: Brianna J. Klein, et al.
Publicado: (2021)